Article PDF
Avoid common mistakes on your manuscript.
References
Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN. First-trimester screening for fetal aneuploidy: biochemistry and muchal translucency. Ultrasound Obstet Gynecol 1997;10:381–6.
De Biasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test. Prenat Diagn 1999;19:360–3.
Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. Antenatal Down syndrome screening in the United States in 2001: a survey survey of maternal-fetal medicine specialists. Am J Obstet Gynecol 2002;187:1230–4.
Haak MC, van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update 2003;9:175–84.
Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867–9.
Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine, and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56–104.
Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s for Down’s syndrome. N Engl J Med 2005;353:2001–11.
Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405–13.
Lau TK, Leung TN. Genetic screening and diagnosis. Curr Opin Obstet Gynecol 2005;17:163–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harry, W.G., Reed, K.L. Nuchal Translucency and First-Trimester Screening. Reprod. Sci. 13, 153–154 (2006). https://doi.org/10.1016/j.jsgi.2006.03.001
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jsgi.2006.03.001